Stay updated on RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Sign up to get notified when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.
Latest updates to the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA Publications section with a full PubMed-cited article and a From PubMed note was added to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check19 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. No user-facing content or layout changes are visible on the page.SummaryDifference0.0%
- Check27 days agoChange DetectedA government funding status notice warning that information may be out of date and that transactions may not be processed has been removed.SummaryDifference0.3%
- Check49 days agoChange DetectedMinor formatting and layout adjustments observed; no changes to core study content such as eligibility, endpoints, or enrollment data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check70 days agoChange DetectedUpgrade notice and operating-status guidance added (v3.2.0), replacing the old version tag (v3.1.0).SummaryDifference3%
- Check77 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
Stay in the know with updates to RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.